These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 21478260)

  • 1. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.
    Hellmann J; Tang Y; Kosuri M; Bhatnagar A; Spite M
    FASEB J; 2011 Jul; 25(7):2399-407. PubMed ID: 21478260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in
    Martínez-Fernández L; González-Muniesa P; Laiglesia LM; Sáinz N; Prieto-Hontoria PL; Escoté X; Odriozola L; Corrales FJ; Arbones-Mainar JM; Martínez JA; Moreno-Aliaga MJ
    FASEB J; 2017 May; 31(5):2135-2145. PubMed ID: 28188173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.
    Yasui M; Tamura Y; Minami M; Higuchi S; Fujikawa R; Ikedo T; Nagata M; Arai H; Murayama T; Yokode M
    PLoS One; 2015; 10(8):e0136304. PubMed ID: 26308623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
    Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
    Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolvin D1 reduces inflammation in co-cultures of primary human macrophages and adipocytes by triggering macrophages.
    Gemperle C; Tran S; Schmid M; Rimann N; Marti-Jaun J; Hartling I; Wawrzyniak P; Hersberger M
    Prostaglandins Leukot Essent Fatty Acids; 2021 Nov; 174():102363. PubMed ID: 34740032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats.
    Li J; Xue YM; Zhu B; Pan YH; Zhang Y; Wang C; Li Y
    J Diabetes Res; 2018; 2018():4627842. PubMed ID: 30225267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.
    Titos E; Rius B; González-Périz A; López-Vicario C; Morán-Salvador E; Martínez-Clemente M; Arroyo V; Clària J
    J Immunol; 2011 Nov; 187(10):5408-18. PubMed ID: 22013115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brd2 disruption in mice causes severe obesity without Type 2 diabetes.
    Wang F; Liu H; Blanton WP; Belkina A; Lebrasseur NK; Denis GV
    Biochem J; 2009 Dec; 425(1):71-83. PubMed ID: 19883376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-γ-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes.
    Saito T; Hasegawa-Moriyama M; Kurimoto T; Yamada T; Inada E; Kanmura Y
    Anesthesiology; 2015 Dec; 123(6):1420-34. PubMed ID: 26492476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.
    Dallaire P; Bellmann K; Laplante M; Gélinas S; Centeno-Baez C; Penfornis P; Peyot ML; Latour MG; Lamontagne J; Trujillo ME; Scherer PE; Prentki M; Deshaies Y; Marette A
    Diabetes; 2008 Aug; 57(8):1999-2011. PubMed ID: 18458147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.
    Odegaard JI; Ricardo-Gonzalez RR; Goforth MH; Morel CR; Subramanian V; Mukundan L; Red Eagle A; Vats D; Brombacher F; Ferrante AW; Chawla A
    Nature; 2007 Jun; 447(7148):1116-20. PubMed ID: 17515919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat.
    Clària J; Dalli J; Yacoubian S; Gao F; Serhan CN
    J Immunol; 2012 Sep; 189(5):2597-605. PubMed ID: 22844113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin promotes macrophage phenotype transition through PI3K/Akt and PPAR-γ signaling during diabetic wound healing.
    Yu T; Gao M; Yang P; Liu D; Wang D; Song F; Zhang X; Liu Y
    J Cell Physiol; 2019 Apr; 234(4):4217-4231. PubMed ID: 30132863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
    Zhang M; Zhou Z; Wang J; Li S
    Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.
    González-Périz A; Horrillo R; Ferré N; Gronert K; Dong B; Morán-Salvador E; Titos E; Martínez-Clemente M; López-Parra M; Arroyo V; Clària J
    FASEB J; 2009 Jun; 23(6):1946-57. PubMed ID: 19211925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.
    Han JH; Shin H; Park JY; Rho JG; Son DH; Kim KW; Seong JK; Yoon SH; Kim W
    FASEB J; 2019 Mar; 33(3):4314-4326. PubMed ID: 30566396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes.
    Russo L; Muir L; Geletka L; Delproposto J; Baker N; Flesher C; O'Rourke R; Lumeng CN
    Mol Metab; 2020 Sep; 39():100983. PubMed ID: 32229247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue macrophages.
    Zeyda M; Stulnig TM
    Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.